Achieving Minimal Disease Activity and Predictors of clinical response in Patients with Psoriatic Arthritis treated with Golimumab in clinical practice: a Multicenter Observational Study (MK-8259-039) First published 03/02/2015 Last updated 27/02/2024 EU PAS number:EUPAS8426 Study Finalised